Related by context. All words. (Click for frequent words.) 68 palivizumab 67 PASI scores 66 severe exacerbations 66 nonsevere 65 trivalent inactivated influenza 64 severe asthma exacerbations 64 salmeterol fluticasone 64 certolizumab 64 rotavirus gastroenteritis 64 neutropenic sepsis 64 C difficile infection 64 amoxicillin clavulanate 63 COPD exacerbation 63 moderate renal impairment 63 definite stent thrombosis 63 venlafaxine XR 63 seroprotection 63 steroid dexamethasone 63 oral FTY# 63 RSV infections 63 external genital lesions 63 MS relapses 63 FluCAM arm 63 dosing frequency 63 fluticasone salmeterol 63 BARACLUDE ® 63 Stent thrombosis 63 Engerix B 62 Infusion Reactions Severe 62 corticosteroid dose 62 relapsed MM 62 HIV HCV coinfected 62 deep venous thromboses 62 recurrent VTE 62 IOP lowering 62 asthma exacerbation 62 divalproex sodium 62 hyperphenylalaninemia HPA due 62 alemtuzumab treated 62 invasive aspergillosis 62 Clostridium difficile infections 62 Motavizumab 62 tetanus diphtheria acellular pertussis 62 reduce serum phosphate 62 candidemia 62 PPSV# 62 morphometric vertebral fractures 62 asthma exacerbations 61 #mg dose [002] 61 7 valent pneumococcal 61 concomitant antibiotics 61 aldosterone antagonist 61 dose Iluvien 61 treatment naive genotype 61 upper gastrointestinal bleeding 61 COPD exacerbations 61 maximally tolerated dose 61 venous thromboembolic events 61 HbA 1c levels 61 XIENCE V demonstrated 61 serious pneumococcal infections 61 MMRV vaccine 61 motavizumab 61 teriflunomide 61 acute gout flares 61 ACTEMRA TM 61 inhospital 61 active ankylosing spondylitis 61 XL# SAR# 61 pneumococcal infection 61 mg/m2 dose 61 antibiotic prophylaxis 61 atherothrombotic events 61 Fluzone Intradermal vaccine 61 RSV prophylaxis 61 reactogenicity 61 chronic HBV 61 rosuvastatin #mg 61 symptomatic VTE 61 symptomatic intracranial 61 #mg ATC 61 CMV infection 61 oxycodone CR 61 receiving XGEVA 61 REYATAZ r arm 61 heFH 61 clazosentan 61 recurrent genital herpes 61 annualized relapse 61 HIV coinfected 61 hsCRP levels 60 vaccinees 60 XIENCE V PROMUS Stent 60 imipenem 60 acute STEMI 60 Pentacel R 60 acellular pertussis DTaP 60 Twinrix 60 pneumococcal pneumonia 60 neutrophil counts 60 KRAS mutations occur 60 postoperative mortality 60 C diff infections 60 im peramivir 60 quadrivalent HPV vaccine 60 viral titers 60 invasive candidiasis 60 meningococcal conjugate vaccine 60 pneumococcal vaccination 60 CCyR 60 tipranavir r 60 fetal malformations 60 placebo dexamethasone 60 CPAP adherence 60 ARCALYST ® 60 nicardipine 60 severe rotavirus gastroenteritis 60 neutropenic fever 60 poor metabolizers 60 attain statistical significance 60 decompensated liver disease 60 C. diff infections 60 paclitaxel eluting stents 60 baseline HbA1c 60 acute respiratory tract infections 60 postprocedure 60 levetiracetam 60 timepoints 60 PLX STROKE targeting 60 dose cohort 60 TNF antagonist 60 intensive statin therapy 60 HBV infections 60 NATRECOR ® 60 ZOSTAVAX 60 TYGACIL 60 vaccine serotypes 60 #mg dose [003] 60 CYPHER Stent 60 intradermal vaccine 60 postexposure 60 VLBW infants 60 salmeterol HFA MDI 60 RSV infection 60 INVEGA ® 60 BCG vaccinated 59 abacavir lamivudine 59 MRSA bloodstream infection 59 venous blood clots 59 ZOLINZA 59 #.#/#.# mmHg [001] 59 hepatorenal syndrome 59 maximal doses 59 nocturnal hypoglycemia 59 #mg/day [001] 59 Non inferiority 59 non metastatic osteosarcoma 59 postoperative infections 59 azilsartan medoxomil 59 iNO 59 CIMZIA TM certolizumab pegol 59 Perforomist Inhalation Solution 59 EDSS score 59 reinfarction 59 prelicensure 59 Influenza vaccination 59 ARCOXIA 59 Serious adverse reactions 59 mcg doses 59 Pneumococcal vaccine 59 dosing cohort 59 CIMZIA ™ 59 nonvertebral fracture 59 PCV7 vaccine 59 Pneumonia vaccine 59 rizatriptan 59 venous thromboembolic disease 59 NATRECOR R 59 NNT = 59 leucopenia 59 eosinophilic asthma 59 recurrent wheezing 59 genotypic resistance 59 Menactra vaccine 59 relapsed ALL 59 C1 INH deficiency 59 glycated hemoglobin levels 59 MAGE A3 ASCI 59 ribavirin therapy 59 forodesine 59 uncontrolled asthma 59 DULERA 59 #OHD levels 59 serum aminotransferase levels 59 revascularizations 59 STELARA ® 59 elevated ALT 59 paliperidone ER 59 antimicrobial prophylaxis 59 NNRTI resistant virus 59 % CI #.#-#.# [007] 59 microbiological eradication 59 TOVIAZ 59 Adenoviruses usually cause 59 tacrolimus ointment 59 ATACAND 59 Chronic ITP 59 hepatitis C genotype 59 recurrent atrial fibrillation 59 8mg/kg 59 TMC# r 59 symptomatic carotid stenosis 59 intravascular hemolysis 59 containing abacavir 59 metastatic lung cancer 59 complete cytogenetic response 59 blood Phe levels 59 HbA1C levels 59 interferon ribavirin 59 MenC 59 Pentacel vaccine 59 dose statin therapy 59 nonvertebral fractures 59 non valvular atrial 59 protease inhibitors PIs 59 SNT-MC#/idebenone 59 micafungin 58 del 5q MDS 58 myocardial infarctions MIs 58 clinically evaluable 58 bronchopulmonary dysplasia 58 stent thromboses 58 achieved ACR# 58 adjunctive placebo 58 angiographic restenosis 58 fluvastatin 58 systemic corticosteroid 58 NPH insulin 58 #mg doses [002] 58 budesonide inhalation suspension 58 URTI 58 canakinumab 58 inhaled budesonide 58 tolterodine ER 58 hemoglobin A1c HbA1c 58 solifenacin 58 statin monotherapy 58 Respiratory syncytial virus 58 serum urate 58 ticlopidine 58 HeFH 58 tigecycline 58 neurodevelopmental impairment 58 recurrent venous thromboembolism 58 postexposure prophylaxis 58 recurrent metastatic 58 methotrexate monotherapy 58 cefepime 58 evaluable subjects 58 CONCERTA 58 conventional antipsychotics 58 Ishak fibrosis score 58 de aths 58 cotrimoxazole 58 EDSS scores 58 mg/m2 cohort 58 atorvastatin #mg 58 microbiologically evaluable 58 PRADAXA #mg 58 nighttime awakenings 58 Interferon beta 1b 58 recurrent tonsillitis 58 PRADAXA 58 events SAEs 58 mitoxantrone plus 58 glycoprotein IIb IIIa inhibitor 58 chronic idiopathic thrombocytopenic purpura 58 diarrheal deaths 58 myelodysplastic myeloproliferative diseases 58 SRBD 58 everolimus eluting stents 58 vaccine LAIV 58 asymptomatic hypothyroidism 58 ALT flares 58 rheumatoid arthritis osteoarthritis ankylosing 58 perioperative mortality 58 antiplatelet medications 58 invasive pneumococcal disease 58 atopic asthma 58 influenzalike illness 58 EDARBI 58 PULMICORT RESPULES 58 hemoglobin A1c levels 58 bicifadine 58 mycophenolate mofetil MMF 58 antiretroviral naive 58 LPV r 58 nevirapine regimen 58 Viral load 58 ACIP recommendations 58 BSIs 58 Xelox 58 dose intramuscular 58 low birthweights 58 octreotide LAR 58 recurrent myocardial infarction 58 CANCIDAS 58 DAS# CRP 58 rimonabant #mg 58 varicella infection 58 Norovirus infection 58 C. difficile infections 58 KRAS mutant tumors 58 binary restenosis 58 Antibiotic resistant infections 58 ARB telmisartan 58 symptomatic aortic stenosis 58 inactivated influenza vaccine 58 galiximab 58 ximelagatran 58 desvenlafaxine succinate 58 Chlamydia infection 58 Hb A1C 58 pulmonary dysfunction 58 attention-deficit/hyperactivity disorder ADHD 58 clopidogrel Plavix 58 mCRC acneform rash 58 rFVIIa 58 perioperatively 58 antibody titer 58 tapentadol ER 58 RSV replication 58 Kaplan Meier estimate 58 HIB vaccine 58 rhinoconjunctivitis 58 spontaneous preterm delivery 58 oral corticosteroid 58 BRIM2 58 generalized edema 58 hyperbilirubinemia 58 ZYVOX 58 Tysabri infusions 58 pegIFN 57 quadrivalent vaccine 57 limiting generalizability 57 herpes zoster vaccine 57 Sanofi Pasteur Fluzone 57 bolus dose 57 serum calcium levels 57 C. diff infection 57 gestational hypertension 57 conjunctival hyperemia 57 acid suppressive medication 57 Complication rates 57 nondiabetic patients 57 recurrent UTI 57 genital herpes infections 57 UPDRS scores 57 S. aureus infection 57 Pharmacokinetic parameters 57 A1c levels 57 bronchial hyperresponsiveness 57 FOLPI 57 perinatal asphyxia 57 shingles herpes zoster 57 MCV4 57 acute cholecystitis 57 sustained virologic response 57 Pneumococcal pneumonia 57 postoperative AF 57 susceptible isolates 57 Live Attenuated Influenza Vaccine 57 thromboembolic complications 57 nosocomial infection 57 S. aureus infections 57 thrombotic complications 57 renal toxicity 57 LC#m# vaccine 57 DASISION 57 squamous cell lung cancer 57 oxcarbazepine 57 oral prednisolone 57 serum phosphate levels 57 HBeAg negative 57 VTE prophylaxis 57 % CI #.#-#.# [008] 57 #mg dose [001] 57 SCIg 57 osteoporotic vertebral compression fractures 57 macrolide antibiotic 57 visceral metastases 57 confirmatory clinical 57 BENICAR HCT 57 receiving VELCADE 57 thrombotic events 57 dalteparin 57 triglyceride concentrations 57 recurrent malignant glioma 57 Cimzia TM 57 lopinavir r arm 57 antiviral efficacy 57 low birthweight infants 57 discontinued Viread 57 hemodynamically significant 57 serum LDL cholesterol 57 related hematological toxicity 57 postoperative morbidity 57 oral diclofenac 57 CHD CVD 57 rebleeding 57 BMI percentiles 57 protease inhibitor PI 57 steroid refractory GvHD 57 High Dose quadruples 57 LRTI 57 neutropenia dehydration dyspnea 57 Erythropoietic therapies may 57 recurrent ischemia 57 ADEs 57 TAXUS p value 57 prednisone prednisolone plus 57 MRSA colonization 57 reintubation 57 rindopepimut 57 DLTs 57 tirofiban 57 partial onset seizures 57 MenACWY 57 LAB CGRP 57 Bloodstream infections 57 heterozygous FH 57 thromboprophylaxis 57 oral anticoagulant therapy 57 diabetic neuropathic pain 57 microgram dose 57 Altastaph 57 perinatal complications 57 perioperative morbidity 57 thrombocytopenic 57 antiarrhythmic drug 57 glycosylated hemoglobin levels 57 respiratory distress syndrome 57 cardiovascular hospitalizations 57 arterial thromboembolic events 57 intradermal injections 57 ARIXTRA 57 chronic HCV genotype 57 myopathy rhabdomyolysis 57 acute rhinosinusitis 57 pulmonary exacerbations 57 phase IIb study 57 suboptimal adherence 57 perinatal mortality 57 CYP#D# inhibitor 57 leukotriene receptor antagonists 57 -#.# log# copies mL 57 CR nPR 57 nadroparin 57 PASI score 57 renal flares 57 OAB symptoms 57 dyslipidaemia 57 Rotavirus vaccine 57 uncomplicated influenza 57 TMP SMX 57 riociguat 57 Folfox 57 plasma HCV RNA 57 IV bisphosphonates 57 CERVARIX 57 HCV RESPOND 2 57 immunosuppressed patients 57 oral corticosteroids 57 preterm deliveries 57 standard chemotherapy regimen 57 PREZISTA r 57 seroconverted 57 Arranon 57 ADCS CGIC 57 serum urate levels 57 4mg/kg 57 inhaled corticosteroid therapy 57 montelukast 57 AGHD 57 Febrile neutropenia 57 Hib vaccination 57 CRESTOR #mg 57 virological response 57 tamoxifen Nolvadex ® 57 BRIM3 57 pyridostigmine 57 febrile neutropenia 57 inhaled iloprost 57 receiving prophylactic anticoagulation 57 empyema 57 Merck RotaTeq 57 APTIVUS r 57 PCV7 57 pneumococcal conjugate 57 zoster vaccine 57 prescribed statins 57 antenatal corticosteroids 57 APTIVUS 57 immuno compromised patients 57 SSTIs 57 hour bronchodilation 57 achieved sustained virological 57 severe hypoglycaemia 57 antiretroviral naïve 57 MenB 56 Skin sterol 56 acromegalic patients 56 rotavirus diarrhea 56 allogeneic HSCT 56 Clinically significant 56 herpes zoster infection 56 hemodialysis patients 56 Adjuvant chemotherapy 56 transaminase elevations 56 CDI recurrence 56 pertussis vaccines 56 enterovirus infection 56 lumiracoxib 56 hypereosinophilic syndrome 56 autoantibody positive 56 persistent wheezing 56 placebo controlled clinical 56 adenoma recurrence 56 valent pneumococcal conjugate vaccine 56 MELD scores 56 biochemical relapse 56 serum phosphorous 56 rALLy 56 plasma triglycerides 56 Postoperative complications 56 smoldering multiple myeloma 56 serum antibody 56 Heterozygous Familial Hypercholesterolemia 56 IFN alfa 56 LEVAQUIN ® 56 mcg albinterferon alfa 2b 56 drank pomegranate juice 56 Chickenpox vaccine 56 anastomotic leak 56 bone marrow reticulin deposition 56 PSADT 56 serum clusterin levels 56 linaclotide treated 56 INSPIRE Trial Phase III 56 hemagglutination inhibition 56 mcg dose 56 NSABP C 56 biologic DMARD 56 seropositivity 56 nonvaccine serotypes 56 LV dysfunction 56 neutropenic 56 pharyngitis tonsillitis 56 null responder HCV 56 neonatal morbidity 56 metabolic syndrome clustering 56 newer atypical antipsychotics 56 Fluzone vaccine 56 elevated triglyceride levels 56 pneumococcal carriage 56 interstitial pneumonia 56 inhaled glucocorticoids 56 ELBW infants 56 naïve HCV 56 adverse reactions incidence 56 hematological toxicity 56 platelet reactivity 56 oral rivaroxaban 56 pertussis tetanus 56 Hydroxyurea 56 HER2 expression 56 serum phosphorus levels 56 measles mumps rubella varicella 56 zolmitriptan 56 intravenous bisphosphonates 56 oral ridaforolimus 56 pioglitazone HCl 56 DEB# 56 HoFH 56 nocturnal awakenings 56 T1DM 56 adult chronic ITP 56 CLA supplementation 56 zidovudine lamivudine 56 systemic toxicity 56 salmeterol inhalation powder 56 AVANDIA 56 varicella chickenpox 56 serum uric acid 56 infliximab Remicade 56 respiratory tract infection 56 VaD 56 treat NNT 56 Opportunistic infections 56 CIN3 56 poorly immunogenic 56 GH deficiency 56 severe renal impairment 56 via intradermal injections 56 oxymorphone ER 56 congenital CMV 56 dexamethasone intravitreal implant 56 receiving antiretroviral therapy 56 plus dexamethasone 56 stable angina pectoris 56 chronic periodontitis 56 primary hypercholesterolemia 56 Mg Uk 56 untreated OSA 56 asthma flare ups 56 NNRTI resistance 56 PREZISTA r arm 56 endometrial hyperplasia 56 coronary artery bypass grafts 56 plus methotrexate 56 azacitidine 56 chorioamnionitis 56 rhinitis sinusitis 56 lymphocyte counts 56 alfa 2a 56 MAS XR 56 prednisone prednisolone 56 postoperative infection 56 heavily pretreated 56 chronic rhinosinusitis 56 severely immunocompromised patients 56 #q# deletion syndrome 56 Platelet counts 56 NOMID 56 mepolizumab 56 Bacille Calmette Guerin BCG 56 Preterm infants 56 immune thrombocytopenic purpura ITP 56 undergoing bariatric surgery 56 intracerebral hemorrhages 56 Rimantadine 56 segment binary restenosis 56 SUSTENNA TM 56 erythema nodosum 56 Raptiva r 56 Acute Decompensated Heart Failure 56 ofpatients 56 convenient dosing regimen 56 atazanavir ritonavir 56 ertapenem 56 fatigue asthenia 56 Heplisav 56 severe hepatic dysfunction 56 administered intramuscularly 56 related bloodstream infections 56 Viread Emtriva 56 acid suppressive therapy 56 Lung transplantation 56 NIHSS score 56 vaginal progesterone gel 56 PCV# 56 cSSSIs 56 immunocompetent patients 56 HI titers 56 adverse cytogenetics 56 using lactulose concomitantly 56 revascularization procedures 56 guanfacine extended release 56 hematological toxicities 56 mmHg diastolic 56 mg administered orally 56 venous thrombotic events 56 preintervention 56 % CI #.#-#.# [003] 56 FDA defined valvulopathy 56 intracranial hemorrhage ICH 56 immune globulin intravenous 56 carotid endarterectomy CEA 56 incidence ≥ 56 ruptured aneurysms 56 ADHF 56 Lipitor #mg 56 receiving VICTRELIS 56 onset sepsis 56 radezolid 56 abnormal Pap smear 56 antibody titres 56 injectable formulations 56 C. difficile colitis 56 beclomethasone dipropionate 56 mg kg dose 56 Myelosuppression 56 lymphocyte count 56 leukotriene receptor antagonist 56 Veramyst 56 Pediarix 56 Cypher Stent 56 anterior uveitis 56 severe hypercholesterolemia 56 chlorambucil 56 aldosterone antagonists 56 demonstrated clinically meaningful 56 unplanned readmissions 56 ACEIs 56 irbesartan 56 thromboembolic events 56 elevated bilirubin 56 Roche Herceptin 56 serum sodium levels 56 Atacand 56 pegylated interferon alpha 56 mild gestational diabetes 56 metformin monotherapy 56 bacteremic 56 orofacial clefts 56 UPPP 56 advanced adenomas 56 dosage regimens 56 nosocomial pneumonia 56 ACUITY trial 56 elevated LDL cholesterol 55 intravitreal injection 55 nonsmall cell lung cancer 55 myocardial infarction ventricular fibrillation 55 Hib disease 55 apneic episodes 55 dose clopidogrel 55 trivalent influenza vaccine 55 HCl capsules 55 QTcF 55 myalgia arthralgia 55 RSD# oral 55 P. falciparum malaria 55 CMV reactivation 55 neurocognitive outcomes 55 metastatic neuroendocrine tumors 55 CALGB # [002] 55 #.#mg/dL 55 postoperative pulmonary 55 refractory CLL 55 MACCE 55 calculated creatinine clearance 55 oseltamivir resistant 55 cerebral vasospasm 55 neurologic complications 55 gonococcal infection 55 inhaled fluticasone 55 Kaplan Meier analysis 55 recurrent glioma 55 aspirin heparin 55 #mmHg [001] 55 ICD therapy 55 neurologic sequelae 55 transaminase levels 55 preventing genital warts 55 medication nonadherence 55 containing LABAs 55 relapsed SCLC 55 neuropsychiatric events 55 Exacerbations 55 colorectal adenoma 55 Primary IGFD 55 postoperative complication 55 leukemia AML 55 corticosteroid therapy 55 serum phosphate 55 Subgroup analyzes 55 Lupuzor ™ 55 perioperative complications 55 samalizumab 55 ESBL producing E. coli 55 Varivax 55 systolic dysfunction 55 FASLODEX 55 SJIA 55 ritonavir boosted atazanavir 55 mixed hyperlipidemia 55 hematologic toxicity 55 prolonged QT interval 55 gadobutrol 55 multivariable analyzes 55 Decompensated Heart Failure 55 persistent pulmonary hypertension 55 invasive fungal infection 55 recurrent glioblastoma multiforme 55 progression TTP 55 inert placebo 55 Pandemic Influenza H#N# 55 eszopiclone 55 serologic testing 55 mcg QD 55 DLQI 55 cystoid macular edema 55 glucocorticoid induced osteoporosis 55 ritonavir boosted protease inhibitor 55 advanced adenoma 55 dengue haemorrhagic fever DHF 55 viral kinetics 55 H Pylori 55 5-FU/LV 55 suppressive therapy 55 Rotavirus causes 55 placebo controlled studies 55 Boostrix 55 bronchiolitis 55 lumiliximab 55 endometriosis ovarian cysts 55 bacterial respiratory infections 55 oxycodone IR 55 chlamydial infection 55 RAPTIVA 55 HBeAg seroconversion 55 ventricular tachyarrhythmia 55 chronic immune thrombocytopenic 55 pertussis immunization 55 invasive Hib 55 Dr. Ramilo 55 systemic embolism 55 KINRIX 55 albiglutide 55 herpes zoster shingles 55 tumor histology 55 CVD mortality 55 Premature Infants 55 Staphylococcus aureus infections 55 lomitapide 55 Flumist 55 intracerebral haemorrhage 55 AML MDS 55 CAMMS# 55 comorbid ADHD 55 Flu Mist nasal spray 55 Meningococcal vaccine 55 Acute Myeloid Leukaemia AML 55 KAPIDEX 55 hepatitis B immunization 55 grade cervical dysplasia 55 ExTRACT TIMI 55 Drug eluting stent 55 budesonide pMDI 55 Pneumococcal vaccines 55 p = ns 55 infantile colic 55 delayed CINV 55 radiologically confirmed 55 syncopal 55 pancreatic resection 55 microgram doses 55 CHAMPION PCI 55 ICD shocks 55 crizotinib PF # 55 antihypertensive medication 55 Vibrio infections 55 zafirlukast 55 H2 blocker 55 Pentacel 55 antiplatelet drugs 55 umol L 55 hours postdose 55 C conjugate vaccine 55 cilostazol 55 Severe hypoglycemia 55 evaluating mipomersen 55 diphtheria tetanus acellular pertussis 55 Operative mortality 55 CAIV T 55 intracerebral hemorrhage 55 Numax 55 Arch Intern Med 55 β blocker 55 chlamydial infections 55 eplerenone 55 TDF FTC 55 neurologic outcomes 55 antipsychotic prescribing 55 otitis media ear 55 pantoprazole Protonix 55 buprenorphine implants 55 TYSABRI therapy 55 mcg BID 55 RLAI 55 neurodevelopmental outcomes 55 pulmonary exacerbation 55 SORT OUT III 55 noninferior 55 digoxin toxicity 55 μg doses 55 anticoagulant warfarin 55 pharmacodynamic properties 55 de novo AML 55 reflux symptoms 55 LNG IUS 55 secondary efficacy endpoint 55 Symptom severity 55 antidiabetic medication 55 NIASPAN 55 vaccine Zostavax 55 preterm neonates 55 vaccine Fluarix 55 rhinovirus infection 55 decitabine 55 pmol liter 55 clinically meaningful improvements 55 Proleukin 55 AST ALT 55 non adjuvanted vaccines 55 grade cervical intraepithelial 55 intracranial stenosis 55 status asthmaticus 55 Zyban bupropion 55 dose cohorts 55 atopic disease 55 fosamprenavir 55 prescribed beta blocker 55 coexisting illnesses 55 locoregional recurrence 55 prescribe Tamiflu 55 dapsone 55 aged ≥ 55 beta blocker therapy 55 Listeria infections 55 flutamide 55 dopaminergic therapy 55 VLBW 55 cisplatin chemotherapy 55 relapsed refractory AML 55 hemorrhagic complications 55 glomerular filtration 55 enzyme elevations 55 NIHSS 55 cytomegalovirus infection 55 q8h 55 lumbar spine BMD 55 dangerous intestinal superbug 55 virologic failure 55 Heavy menstrual bleeding 55 tenofovir emtricitabine 55 histologic subtype 55 inactivated poliovirus 55 AA Amyloidosis 55 ibandronate 55 inhaled steroid 55 elevated serum creatinine 55 invasive MRSA infections 55 ritonavir boosted 55 pyrexia mucositis sepsis febrile 55 PREVENAR 55 pentoxifylline 55 neutropaenia 55 exposed prenatally 55 RSV bronchiolitis 55 non hematological toxicities 55 systemic corticosteroids 55 intravitreal injections 55 prescribed antipsychotics 55 4CMenB 55 Varicella chicken pox 55 adefovir treated 55 Proellex TM 55 CK # plasma concentrations 55 Hypotension 55 PEDIARIX 55 experienced virologic failure 55 amalgam fillings mercury vapor 55 PSA nadir 55 hypophosphatemia 55 unfavorable cytogenetics 55 headache abdominal pain 55 overt hepatic encephalopathy HE 55 nulliparous women 55 beta blockers ACE inhibitors 55 Vaccine Recombinant 55 Pegasys peginterferon alfa 2a 55 PPSV 55 ANCHOR trial 55 co trimoxazole 55 postdischarge 55 diphtheria pertussis whooping cough 55 pioglitazone hydrochloride 55 buprenorphine naloxone 55 Riluzole 55 REGN# 55 Pneumococcal vaccination 55 basiliximab 55 #I TM# 55 angioneurotic edema 55 ALT elevations 55 oral rotavirus vaccine 55 habitual snoring 55 discontinuations due 55 pretreatment serum 55 thetreatment 55 liver histology 55 treatment naïve genotype 55 Tolamba 55 rotavirus infection 55 nucleotide analog 55 AVODART 55 coinfected patients